The announcement of guidance is a critical event for any company as it provides investors with a forecast of future earnings and performance. For AbbVie, this announcement appears to have led to a negative reaction from the market, likely due to concerns over the company's future profitability or growth prospects. This is reflected in the stock trading lower, indicating a short-term bearish outlook from investors.